MORGAN GANT: Open Payments
NPI 1275848780 · CARTERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,481 in 150 payments from 12 companies in 2025. Trend: 2023 $1,954 · 2024 $2,319 · 2025 $2,481
Food & beverage: $2,331Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $453 |
| Corium, LLC | 28 | $356 |
| Axsome Therapeutics, Inc. | 20 | $317 |
| Otsuka America Pharmaceutical, Inc. | 25 | $312 |
| ABBVIE INC. | 14 | $244 |
| Vanda Pharmaceuticals Inc. | 13 | $182 |
| Alkermes, Inc. | 11 | $167 |
| Janssen Pharmaceuticals, Inc | 12 | $162 |
| JAZZ PHARMACEUTICALS INC. | 1 | $150 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
Products named: CAPLYTA, Azstarys, REXULTI, Auvelity, VRAYLAR, FANAPT, ARISTADA, SPRAVATO.
Industry payments across IL — which companies pay providers there.
